H.R. 980 (108th): Access to Innovation for Medicare Patients Act of 2003

108th Congress, 2003–2004. Text as of Feb 27, 2003 (Introduced).

Status & Summary | PDF | Source: GPO

HR 980 IH

108th CONGRESS

1st Session

H. R. 980

To amend title XVIII of the Social Security Act to expand Medicare coverage of certain self-injected biologicals.

IN THE HOUSE OF REPRESENTATIVES

February 27, 2003

Ms. DUNN (for herself, Mr. MCDERMOTT, Mr. PICKERING, Mrs. CAPPS, Mr. INSLEE, Mr. CRANE, Mr. GREENWOOD, Mr. DICKS, Mr. HASTINGS of Washington, Mr. ABERCROMBIE, Mr. MCNULTY, Mr. KLECZKA, Mr. PAUL, and Mr. FROST) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned


A BILL

To amend title XVIII of the Social Security Act to expand Medicare coverage of certain self-injected biologicals.

    Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ‘Access to Innovation for Medicare Patients Act of 2003’.

SEC. 2. MEDICARE COVERAGE OF SELF-INJECTED BIOLOGICALS.

    (a) COVERAGE- Section 1861(s)(2) of the Social Security Act (42 U.S.C. 1395x(s)(2)) is amended--

      (1) by striking ‘and’ at the end of subparagraph (U);

      (2) by inserting ‘and’ at the end of subparagraph (V); and

      (3) by adding at the end the following new subparagraph:

      ‘(W) a self-injected biological (which is approved by the Food and Drug Administration) that is prescribed as a complete replacement for a drug or biological that would otherwise be described in subparagraph (A) or (B);’.

    (b) EFFECTIVE DATE- The amendments made by subsection (a) shall apply to biologicals furnished on or after January 1, 2004.